Literature DB >> 29616332

Author's reply: can budesonide form be alterative treatment for ulcerative proctosigmoiditis?

Makoto Naganuma1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29616332     DOI： 10.1007/s00535-018-1462-2

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  3 in total

1.  Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis.

Authors:  William J Sandborn; Brian Bosworth; Salam Zakko; Glenn L Gordon; David R Clemmons; Pamela L Golden; Robert L Rolleri; Jing Yu; Andrew C Barrett; Enoch Bortey; Craig Paterson; William P Forbes
Journal:  Gastroenterology       Date:  2015-01-30       Impact factor: 22.682

2.  Correction to: Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study.

Authors:  Makoto Naganuma; Nobuo Aoyama; Tomohiro Tada; Kiyonori Kobayashi; Fumihito Hirai; Kenji Watanabe; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2018-04       Impact factor: 7.527

3.  Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.

Authors:  Makoto Naganuma; Nobuo Aoyama; Yasuo Suzuki; Haruo Nishino; Kiyonori Kobayashi; Fumihito Hirai; Kenji Watanabe; Toshifumi Hibi
Journal:  J Crohns Colitis       Date:  2015-11-16       Impact factor: 9.071
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.